{
    "2021-03-08": [
        [
            {
                "time": "2023-03-08",
                "original_text": "【招商策略】新成立基金规模回升，美债收益率持续上行——金融市场流动性与监管动态周报（0308）",
                "features": {
                    "keywords": [
                        "基金规模",
                        "美债收益率",
                        "流动性",
                        "监管动态"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "复星医药(02196)：每手“17 复药 01”将于3月15日派息34.8元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "派息",
                        "17复药01"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "复星医药(02196.HK)“17复药01”将于3月15日付息",
                "features": {
                    "keywords": [
                        "复星医药",
                        "付息",
                        "17复药01"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-08",
                "original_text": "医药行业一周观察：大小市值表现分化 关注二线优质公司的机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "市值分化",
                        "二线公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-03-08",
                "original_text": "复星医药：控股子公司复星实业持有BioNTech普通股158.08万股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BioNTech",
                        "控股子公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-08",
                "original_text": "【异动股】复星医药(02196-HK)跌4.77%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "异动股",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-08",
                "original_text": "70只港股获南向资金大比例持有",
                "features": {
                    "keywords": [
                        "港股",
                        "南向资金",
                        "大比例持有"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}